Back to the Annual Review

Continuing to support the work of NCRI Groups to co-ordinate the development of high quality, strategically important, research.

Leveraging the power of the research community, consumers and Partners working via the NCRI Groups, scoping new grant calls and identifying high-quality research proposals eligible for existing funding schemes.

Resetting the relationships with MRC and NIHR, supporting them in their aims to receive fewer, but higher quality research proposals in cancer.

Improving the quality of research calls and research proposals by offering Proposal Guidance meetings to NCRI Groups and Partners. We will continue to be flexible in how these meetings are run to suit the topic under consideration.

Completing research prioritisation exercises with Prostate, Radiotherapy, Sarcoma, Upper Gastrointestinal, Children’s, SPED, Colorectal, Haematological Oncology and Lymphoma Groups, publishing and actively disseminating outputs.

Working with NCRI Consumers and the Consumer Involvement Advisory Group to further develop our consumer work towards a more focused policy and advocacy role.

Continuing to develop the Dragons’ Den sessions to a wider community if possible and formalise our links with industry to provide the patient/carer voice in the development of industry studies.

Continuing to support Early Career Researchers ensuring a suitable number of opportunities are on offer to ensure retention of those that have signed up to our network. ECRs benefitting from being involved across all NCRI activities from the NCRI Groups, Proposals Guidance meetings, working with Key Opinion Leaders and working with Consumers.

Delivering an events programme that will tie into the work of the NCRI Groups and build on the previous successes of our Beyond the Horizon series looking at topics of particular interest to the cancer research community.

Developing our new strategy for 2023-2028 to be launched later in the year along with a new Partner proposition and funding model.